Skip to main content

ScienceDex / Researcher record

Vasile Pandrea, Ivona

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #3,863
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$2M
Full award amounts, FY2023
3
Records listing this PI
#3,863
By linked amount among FY2023 PIs
2008
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2008$383,6931#17,573
2009$894,9612#9,102
2010$329,1661#26,066
2012$756,0421#9,663
2013$703,1671#10,007
2014$725,7281#10,101
2015$1,620,7183#3,721
2016$1,537,9783#3,929
2017$1,491,5412#4,082
2018$1,516,7092#4,253
2019$779,9031#11,284
2020$779,6201#4,550
2021$1,170,5722#7,612
2022$1,178,3152#7,921
2023$1,972,8093#3,863

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20081 record
  2. FY20092 records
  3. FY20101 record
  4. FY20121 record
  5. FY20131 record
  6. FY20141 record
  7. FY20153 records
  8. FY20163 records
  9. FY20172 records
  10. FY20182 records
  11. FY20191 record
  12. FY20201 record
  13. FY20212 records
  14. FY20222 records
  15. FY2023 · selected3 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vasile Pandrea, Ivona. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Pathology

FY2023 award records by amount

NIH award records listing Vasile Pandrea, Ivona as a PI. Multi-PI records show the full award amount for context.

  • 1R01AI179317-01R01Contact PI
    Probing the role of adenosine pathway in SIV pathogenesis
    University of Pittsburgh · Pathology (NIH department code)
    $794K
    award amount
  • 5R01HL123096-06R01Contact PI
    Impact of NETosis on SIV Pathogenesis and Response to Treatment
    University of Pittsburgh · Pathology (NIH department code)
    $781.3K
    award amount
  • 5R01DK130481-03R01Contact PI
    Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
    University of Pittsburgh · Pathology (NIH department code)
    $397.5K
    award amount

Award organization

Organizations that administered FY2023 awards listing Vasile Pandrea, Ivona as a PI.

FY2023 award administered by University of Pittsburgh (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    University of Pittsburgh
  2. 2009
    $500K Cumulative Funding
  3. 2009
    $1M Cumulative Funding
  4. 2009
    Entered Top 50% Nationally
    Ranked #9102
  5. 2012
    $2M Cumulative Funding
  6. 2014
    R01 Grant Holder
  7. 2015
    $5M Cumulative Funding
  8. 2015
    Entered Top 25% Nationally
    Ranked #3721
  9. 2019
    $10M Cumulative Funding